Skip to main content

Advertisement

Log in

Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

In addition to chronic hepatitis, many individuals infected with hepatitis C virus (HCV) suffer from fatigue, which may compromise their health-related quality of life (HRQL). To assess systematically health-related quality of life (HRQL) in patients with chronic hepatitis C and to determine if any clinical, biochemical, virologic, demographic, and histologic features are associated with HRQL status. In this cross-sectional observational study, one hundred thirty patients with chronic HCV infection (HCV RNA positive by PCR) and 61 healthy controls were enrolled from a tertiary care teaching medical center. All patients and controls completed one generic HRQL questionnaire (MOS SF-36) and one liver-disease specific instrument (Chronic Liver Disease Questionnaire, CLDQ). Ninety-five HCV patients and all the controls also completed a fatigue questionnaire (Chronic Fatigue Screener, CFS) and had immunologic markers determined (Cryoglobulin, Soluble IL-2 receptors, Rheumatoid Factor). We compared the HRQL of HCV-infected patients to the controls and, using data from other studies, to the general population, patients with diabetes, and patients with chronic low back pain. Patients with chronic HCV had greater HRQL impairment than healthy controls and those with type II diabetes. Fatigue was the most important symptom with negative impact on HRQL. Sixty-one percent of HCV-infected patients reported fatigue-related loss of activity. Additionally, other factors associated with HRQL were gender and histologic cirrhosis. Chronic HCV infection has a profound negative impact on patients’ HRQL. Disabling fatigue is the most important factor that contributes to loss of well-being in this relatively young group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. World Health Organization (2000) Hepatitis C – Factsheet No 164. Revised October 2000. WHO, Geneva

    Google Scholar 

  2. Davis G (guest ed) (1997) Hepatitis C. Clin Liver Dis 1(3):494–704

    Google Scholar 

  3. Alter M (1997) Epidemiology of hepatitis C. Hepatology 26(3, Suppl. 1):62S–65S

    Article  PubMed  CAS  Google Scholar 

  4. Hoofnagle J, Tralka TS (1997) The national institute of health consensus development conference: management of hepatitis C. Hepatology 26(3, Suppl. 1):1S–10S

    Article  Google Scholar 

  5. McMurray RW, Elbourne K (1997) Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 26(4): 689–701

    Article  PubMed  CAS  Google Scholar 

  6. Pawlotsky JM, Yahia MB, Andre C et al (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19(4):841–848

    Article  PubMed  CAS  Google Scholar 

  7. Sawada T, Hirohata S, Inoue T, Ito K (1991) Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 34:1620–1621

    PubMed  CAS  Google Scholar 

  8. Siegel L, Cohn L, Nashel D (1993) Rheumatic manifestations of hepatitis C infection. Semin Arthritis Rheum 23(3):149–154

    Article  PubMed  CAS  Google Scholar 

  9. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi M-F, Ruggiero G (1996) Epidemiology, clinical spectrum and prognostic value of mixed cyroglobulinemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 28:1–9

    PubMed  CAS  Google Scholar 

  10. Rubin LA, Nelson DL (1990) The soluble interleukin—2 receptor: biology, function, and clinical application. Ann Int Med 113:619–627

    PubMed  CAS  Google Scholar 

  11. Davis G, Balart L, Schiff E, Lindsay K, Bodenheimer, Perrillo R, Carey W, Jacobson, Payne J, Dienstag J, van Thiel D, Tamburro C, Martino F, Sangvhi B, Albrecht J (1994) Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clin Ther 16:334–345

    PubMed  CAS  Google Scholar 

  12. Carithers R, Sugano D, Bayliss M (1996) Health assessment for chronic HCV: results of quality of life. Dig Dis Sci 41(12, Suppl.):75S

    Article  PubMed  Google Scholar 

  13. Foster G, Goldin R, Thomas H (1998) Chronic hepatitis C infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 27(1):209–212

    Article  PubMed  CAS  Google Scholar 

  14. Bonkovsky H, Woolley J, Consensus Interferon Study Group (1999) Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 29(1):264–269

    Article  PubMed  CAS  Google Scholar 

  15. Bombardier CH, Buchwald D (1995) Outcome and prognosis of patients with chronic fatigue vs. chronic fatigue syndrome. Arch Intern Med 155(19):2105–2110

    Article  PubMed  CAS  Google Scholar 

  16. Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A, International Chronic Fatigue Syndrome Study Group (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121(12):953–959

    PubMed  CAS  Google Scholar 

  17. Ware J, Sherbourne C (1992) The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–482

    Article  PubMed  Google Scholar 

  18. Ware J, Kosinski M, Keller S (1994) SF-36 physical and mental health summary scales: a user’s manual. The Health Institute, Boston, MA

    Google Scholar 

  19. Younossi Z, Guyatt, G, Kiwi M, King D, Bohprai N (1999) Development of a disease-specific health-related quality of life index for chronic liver disease. GUT 44:1–6

    Article  Google Scholar 

  20. Guyatt G, Walter S, Norman G (1987) Measuring change over time: assessing the usefulness of evaluative instrument. J Chron Dis 40:171–178

    Article  PubMed  CAS  Google Scholar 

  21. Jaeschke R, Guyatt G, Keller J, Singer J (1989) Measurement of health status: ascertaining the meaning of a change in quality-of-life questionnaire score. Controlled Clin Trials 10:407–415

    Article  PubMed  CAS  Google Scholar 

  22. Henry JB (1979) Clinical diagnosis and management by laboratory methods (16th ed.). Philadelphia, PA: WB Saunders Company

  23. Norbert W, Tietz M (1978) Fundamentals of clinical chemistry (3rd ed.). Philadelphia, PA: WB Saunders Company

  24. Rubin L, Nelson D (1990) The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 113:619–627

    PubMed  CAS  Google Scholar 

  25. Turcotte JG, Lambert MJ III (1973) Variceal hemorrhage, hepatic cirrhosis, and portacaval shunts. Surgery 73:810–817

    PubMed  CAS  Google Scholar 

  26. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus varices. Br J Surg 60:646–649

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This research was supported in part by grants from the I.H. Page Centre for Clinical Effectiveness of the Cleveland Clinic Foundation and an unrestricted educational grant from WT Grant to LC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zobair M. Younossi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kallman, J., O’Neil, M.M., Larive, B. et al. Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection. Dig Dis Sci 52, 2531–2539 (2007). https://doi.org/10.1007/s10620-006-9708-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9708-x

Keywords

Navigation